GMAB · Healthcare · $21.2B
After-hours $34.550.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출 성장률이 25%로 나오면서 직전 가이던스 14% 성장 전망에서 크게 위로 뛰었어요.”
In the company's words · 2026 2분기 earnings call